Objective:To investigate the safety, feasibility, and efficacy of pneumoperitoneum-assisted laparoscopic thyroidectomy via the subclavian approach (PSTSA) .Methods:Retrospective analysis of the clinical data of 24 papillary thyroid carcinoma (PTC) patients who underwent PSTSA,from Nov. 1,2024 to Dec. 31,2024 in Zhongshan Hospital of Xiamen University was performed. Data including the maximum tumor diameter,surgical duration,volume of drainage fluid,number of lymph nodes cleared,postoperative complications,cosmetic outcomes, and total hospitalization time were recorded.Results:All 24 cases were preoperatively diagnosed with PTC, with 12 female and 12 male patients.All cases were successfully completed without conversion to open surgery.The maximum tumor diameter in the pathological sections was 0.51±0.21 cm,the surgical duration was 71.54±11.62 minutes, the number of central compartment lymph nodes retrieved was 6.29±2.82 units,and the number of positive lymph nodes was 0.46±0.93.No CO2 gas embolism occurred during the surgery,and no postoperative complications such as hoarseness,numbness of hands and feet,or postoperative bleeding were observed.Conclusions:Pneumoperitoneum-assisted laparoscopic thyroidectomy via the subclavian approach (pneumoperitoneum-assisted laparoscopic thyroidectomy via the subclavian approach, PSTSA) is a safe and feasible surgical method for thyroidectomy.

Objective:To investigate the safety, feasibility, and efficacy of pneumoperitoneum-assisted laparoscopic thyroidectomy via the subclavian approach (PSTSA) .Methods:Retrospective analysis of the clinical data of 24 papillary thyroid carcinoma (PTC) patients who underwent PSTSA,from Nov. 1,2024 to Dec. 31,2024 in Zhongshan Hospital of Xiamen University was performed. Data including the maximum tumor diameter,surgical duration,volume of drainage fluid,number of lymph nodes cleared,postoperative complications,cosmetic outcomes, and total hospitalization time were recorded.Results:All 24 cases were preoperatively diagnosed with PTC, with 12 female and 12 male patients.All cases were successfully completed without conversion to open surgery.The maximum tumor diameter in the pathological sections was 0.51±0.21 cm,the surgical duration was 71.54±11.62 minutes, the number of central compartment lymph nodes retrieved was 6.29±2.82 units,and the number of positive lymph nodes was 0.46±0.93.No CO2 gas embolism occurred during the surgery,and no postoperative complications such as hoarseness,numbness of hands and feet,or postoperative bleeding were observed.Conclusions:Pneumoperitoneum-assisted laparoscopic thyroidectomy via the subclavian approach (pneumoperitoneum-assisted laparoscopic thyroidectomy via the subclavian approach, PSTSA) is a safe and feasible surgical method for thyroidectomy.

Objective: To summarize the clinical effects of Shuxuening Injection on diseases and evaluate the quality of evidence to provide reference for the clinical application of Shuxuening Injection. Methods: Journal articles and conference papers were retrieved from the databases CNKI, Wanfang, VIP, CBM, EMbase, Pubmed and Cochrane with thematic word"Shuxuening"in Chinese and English, then all forms of clinical studies were screened and the disease types and frequency were analyzed, the dominant disease types of Shuxuening Injection were identified. Futhermore, RCT was extracted, and the literature quality was graded using the cochrane manual recommendation method, and its effectiveness and safety were evaluated. Results: All clinical research results show that Shuxuening Injection to treat disease with as many as 74 kinds of varieties, mainly circulation system disease and neural system disease, followed by endocrine disease, respiratory disease, scattered remaining research in ten other system diseases. These researches appeared with the highest frequency of the three diseases were cerebral infarction and its aftermath, angina pectoris and coronary heart disease, diabetes mellitus and its complication. A total of 337 RCT articles were included, all of which were of poor quality. In general, the efficiency of Shuxuening Injection treatment group was significantly higher than that of the control group, with a total efficiency of 84.48％. There were 21.96％ references to adverse reactions, but all of them were minor adverse reactions, such as pruritus, which generally got better by itself or after treatment. Conclusion:Shuxuening Injection has a wide range of clinical application and remarkable effect, especially for the ischemic diseases of cardiovascular and cerebrovascular diseases with good efficacy, less adverse reactions and safety. However, the quality of evidence is generally poor, which needs further study.